These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23939649)
1. Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia. Endocrine Society Am Fam Physician; 2013 Jul; 88(2):142-4. PubMed ID: 23939649 [No Abstract] [Full Text] [Related]
2. Drugs for hypertriglyceridemia. Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119 [No Abstract] [Full Text] [Related]
3. Hypertriglyceridemia: A review of the evidence. Elkins C; Friedrich D Nurse Pract; 2018 Oct; 43(10):22-29. PubMed ID: 30153192 [TBL] [Abstract][Full Text] [Related]
4. [Introduction to drug therapy]. Ishii H; Yoshida M Nihon Rinsho; 2013 Sep; 71(9):1636-40. PubMed ID: 24205727 [TBL] [Abstract][Full Text] [Related]
6. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy. Preiss D Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227 [No Abstract] [Full Text] [Related]
7. Patient information page from The Hormone Foundations. Patient guide to the assessment and treatment of hypertriglyceridemia (high triglycerides). Berglund L; Brunzell J; Sacks FM J Clin Endocrinol Metab; 2012 Sep; 97(9):31A-32A. PubMed ID: 22962678 [No Abstract] [Full Text] [Related]
8. [Fibrates: their prescription must be restricted]. Béliard-Lasserre S Rev Prat; 2015 Dec; 65(10):1243-4. PubMed ID: 26979011 [No Abstract] [Full Text] [Related]
9. Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics. Brisson D; Méthot J; Tremblay K; Tremblay M; Perron P; Gaudet D Pharmacogenet Genomics; 2010 Dec; 20(12):742-7. PubMed ID: 21217359 [TBL] [Abstract][Full Text] [Related]
10. Approach to Hypertriglyceridemia in the Pediatric Population. Valaiyapathi B; Sunil B; Ashraf AP Pediatr Rev; 2017 Sep; 38(9):424-434. PubMed ID: 28864733 [TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridemia: its etiology, effects and treatment. Yuan G; Al-Shali KZ; Hegele RA CMAJ; 2007 Apr; 176(8):1113-20. PubMed ID: 17420495 [TBL] [Abstract][Full Text] [Related]
12. Paradoxical decrease in serum high-density lipoprotein cholesterol with Tredaptive® (m/r nicotinic acid 1 g and laropiprant 20 mg). Sharpe P Ann Clin Biochem; 2011 Nov; 48(Pt 6):584-5. PubMed ID: 21868415 [No Abstract] [Full Text] [Related]
13. A New Beginning for Triglyceride-Lowering Therapies. Pradhan AD Circulation; 2019 Jul; 140(3):167-169. PubMed ID: 30836784 [No Abstract] [Full Text] [Related]
14. Triglycerides and endothelial function: molecular biology to clinical perspective. Kajikawa M; Higashi Y Curr Opin Lipidol; 2019 Oct; 30(5):364-369. PubMed ID: 31348023 [TBL] [Abstract][Full Text] [Related]
15. Commentary. Secondary causes of hypertriglyceridemia and pancreatitis. Wagh A; Stone NJ Clin Chim Acta; 2003 Jun; 332(1-2):21. PubMed ID: 12763275 [No Abstract] [Full Text] [Related]
16. [Management of hypertriglyceridemia in children]. Dobashi K Nihon Rinsho; 2013 Sep; 71(9):1670-5. PubMed ID: 24205733 [TBL] [Abstract][Full Text] [Related]